<!DOCTYPE ArticleSet PUBLIC '-//NLM//DTD PubMed 2.8//EN' 'https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd'>
<ArticleSet>
	<Article>
		<Journal>
			<PublisherName>International Rhinologic Society</PublisherName>
			<JournalTitle>Rhinology</JournalTitle>
			<Issn>0300-0729</Issn>
			<PubDate PubStatus='aheadofprint'>
				<Year>2026</Year>
				<Month>04</Month>
				<Day>16</Day>
			</PubDate>
		</Journal>
		<ArticleTitle>Chronic rhinosinusitis in a birth cohort: symptom trajectories and early-life risk factors up to young adulthood </ArticleTitle>
		<Language>EN</Language>
		<AuthorList>
			<Author>
				<FirstName>K.</FirstName>
				<LastName>Åberg</LastName><AffiliationInfo><Affiliation>Department of Clinical Science, Intervention and Technology, Division of Ear, Nose and Throat Diseases, Karolinska Institutet, Stock-holm, Sweden</Affiliation>
			</AffiliationInfo><AffiliationInfo><Affiliation>Medical unit Head Neck Lung and Skin cancer, Department of Head and Neck Surgery, Karolinska University Hospital, Stockholm, Sweden</Affiliation>
			</AffiliationInfo>
			</Author>
			<Author>
				<FirstName>A.</FirstName>
				<LastName>Asarnoj</LastName><AffiliationInfo><Affiliation>Department of Women’s and Children's Health, Karolinska Institutet, Stockholm, Sweden</Affiliation>
			</AffiliationInfo><AffiliationInfo><Affiliation>Astrid Lindgren’s Children’s Hospital, Karolinska University Hospital, Stockholm, Sweden</Affiliation>
			</AffiliationInfo>
			</Author>
			<Author>
				<FirstName>A.</FirstName>
				<LastName>Asarnoj</LastName><AffiliationInfo><Affiliation>Department of Women’s and Children's Health, Karolinska Institutet, Stockholm, Sweden</Affiliation>
			</AffiliationInfo><AffiliationInfo><Affiliation>Astrid Lindgren’s Children’s Hospital, Karolinska University Hospital, Stockholm, Sweden</Affiliation>
			</AffiliationInfo>
			</Author>
			<Author>
				<FirstName>L.O.</FirstName>
				<LastName>Cardell</LastName><AffiliationInfo><Affiliation>Department of Clinical Science, Intervention and Technology, Division of Ear, Nose and Throat Diseases, Karolinska Institutet, Stock-holm, Sweden</Affiliation>
			</AffiliationInfo><AffiliationInfo><Affiliation>Department of Ear, Nose and Throat Diseases, Karolinska University Hospital, Stockholm, Sweden</Affiliation>
			</AffiliationInfo>
			</Author>
			<Author>
				<FirstName>I.</FirstName>
				<LastName>Kull</LastName><AffiliationInfo><Affiliation>Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet, Stockholm, Sweden</Affiliation>
			</AffiliationInfo><AffiliationInfo><Affiliation>Sachs’ Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden</Affiliation>
			</AffiliationInfo>
			</Author>
			<Author>
				<FirstName>A.</FirstName>
				<LastName>Bergström</LastName><AffiliationInfo><Affiliation>Department of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden</Affiliation>
			</AffiliationInfo><AffiliationInfo><Affiliation>Center for Occupational and Environmental Medicine, Region Stockholm, Sweden</Affiliation>
			</AffiliationInfo>
			</Author>
			<Author>
				<FirstName>E.</FirstName>
				<LastName>Melén</LastName><AffiliationInfo><Affiliation>Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet, Stockholm, Sweden</Affiliation>
			</AffiliationInfo><AffiliationInfo><Affiliation>Sachs’ Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden</Affiliation>
			</AffiliationInfo>
			</Author>
			<Author>
				<FirstName>M.</FirstName>
				<LastName>Holmström</LastName>
			<Affiliation>Department of Clinical Science, Intervention and Technology, Division of Ear, Nose and Throat Diseases, Karolinska Institutet, Stock-holm, Sweden</Affiliation>
			</Author>
			<Author>
				<FirstName>M.</FirstName>
				<LastName>van Hage</LastName><AffiliationInfo><Affiliation>Department of Medicine Solna, Division of Immunology and Respiratory Medicine, Karolinska Institutet, Stockholm, Sweden</Affiliation>
			</AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden</Affiliation>
			</AffiliationInfo><AffiliationInfo><Affiliation>Center for Molecular Medicine, Karolinska University Hospital Stockholm, Sweden</Affiliation>
			</AffiliationInfo>
			</Author>
			<Author>
				<FirstName>M.</FirstName>
				<LastName>Westman</LastName>
			<Affiliation>Department of Medicine Huddinge, Clinical Lung and Allergy Research Unit, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden</Affiliation>
			</Author>
		</AuthorList>
<PublicationType>Journal Article</PublicationType>
		<ArticleIdList>
			<ArticleId IdType='pii'>3452</ArticleId>
			<ArticleId IdType='doi'>10.4193/Rhin26.079</ArticleId>
		</ArticleIdList>
		<Abstract>
	    	BACKGROUND: Chronic rhinosinusitis (CRS) is common worldwide in adults, but development of CRS has rarely been studied longitudinally in birth-cohorts. The aim was to investigate development of upper airway symptoms from childhood to young adulthood and to identify early risk factors for CRS at 24 years, in a population-based birth cohort.
METHOD: 3037 subjects from the BAMSE (Barn/children Allergy Milieu Stockholm Epidemiology) cohort had complete question-naire answers on CRS at the 24-year-follow-up. Subjects fulfilling European Position Paper on Rhinosinusitis (EPOS) criteria of CRS at 16 and/or 24 years (n=141) were invited to a clinical examination with nasal endoscopy and interviews.  Among these, 68 had clinically verified CRS symptoms. Symptoms and clinical status were compared with questionnaire-based answers on symptoms and potential risk factors for CRS, in early childhood.
RESULTS: Among subjects with CRS symptoms at 24 years, &amp;gt; 60% reported upper airway symptoms already at 16 years. In the same group, a significant association was observed with a history of otitis media &amp;lt; 1 year and with heredity for atopic diseases. Moreover, the proportion of atopic features such as asthma, allergic rhinitis and eczema were significantly higher at 4, 8 and 16 years in this group. No clear association was found between CRS at 24 years and early RS infection, antibiotic use
		</Abstract>
	</Article>
</ArticleSet>